Lena Biosciences logo

Lena Biosciences

3D Cell Culture & Perfused-Organ-Panel MPS Technology

4 employees · est. 2008 · Atlanta, United States

VS
mo:re logo

mo:re

3D Cell Culture - Automated, verified, standardized

12 employees · est. 2023 · Hamburg, Germany

Lena Biosciences is the older company (2008 vs 2023); mo:re is the larger of the two.

Side-by-Side Comparison

Lena Biosciences mo:re
Founded
2008 older 2023
Headquarters
Atlanta, United States Hamburg, Germany
Employees
4 12 larger
Industry
Biotechnology, Life Sciences, Pharmaceutical Biotechnology, Pharmaceutical, Robotics
Funding Stage
Grant Seed
Total Funding
$2.61M $2.50M
Funding Rounds
9 2
Services
Not tracked yet Standardized tissue cultures and protocols, Automation of lab processes, Integrated lab platforms, High-quality and reproducible experimental outcomes
Target Customers
Not tracked yet Pharmaceutical companies, Biotechnology firms, Research laboratories, Academic institutions involved in drug development
Taxonomy
Organ-on-a-chip, 3D Cell Culture, Drug Testing, Precision Therapies, Biomedical Research, Cancer Research, Cell Culture Technology, Perfusion Systems, High-throughput Screening, Drug Metabolism, ADME Tox Screening, Monoclonal Antibodies, IPSC, Toxicity Testing 3D Cell Culture, Organoid Generation, Automated Workflows, Drug Discovery, NAM (New Approach Methodology), Life Science Research, R&D Pipeline, Regulatory Approval Preparation, Quality Control, Regulatory-grade Traceability, IND Submissions, GMP Compliance, Lab Platform, Biotechnology Automation, Toxicology Testing
Website
lenabio.com more.science
Lena Biosciences logo

About Lena Biosciences

Lena Biosciences is a biotechnology company founded in 2008, with headquarters in the United States. The company specializes in simplifying 3D cell culture and addressing common issues encountered by scientists in the lab. Lena Biosciences offers advanced Perfused-Organ-Panel (MPS) technology and 3D...

mo:re logo

About mo:re

mo:re is a burgeoning player in the Biotechnology and Pharmaceutical sectors, ingeniously converging with Robotics to enhance research efficiencies. Founded in 2023 and headquartered in Germany, the company’s flagship product, MO:BOT, presents a revolutionary leap with its fully automated platform d...

We will tell you when either one moves

BounceWatch watches Lena Biosciences and mo:re for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Lena Biosciences and mo:re — by email.

Frequently Asked Questions

Lena Biosciences — 3D Cell Culture & Perfused-Organ-Panel MPS Technology . mo:re — 3D Cell Culture - Automated, verified, standardized. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Lena Biosciences has raised $2.61M while mo:re has raised $2.50M.
Lena Biosciences and mo:re operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Lena Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Lena Biosciences on 12 Sep 2024, and mo:re on 12 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy